XML 104 R91.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ (DEFICIT) EQUITY - Schedule of Stock Option Activity (Details)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2022
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Beginning balance (in shares) | shares 31,942
Options granted (in shares) | shares 0
Exercise of stock options (in shares) | shares (1,321)
Options forfeited (in shares) | shares (5,528)
Options expired (in shares) | shares (1,178)
Ending balance (in shares) | shares 23,915
Options vested and expected to vest (in shares) | shares 23,915
Options vested and exercisable (in shares) | shares 7,521
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Beginning balance, weighted average exercise price (in dollars per share) | $ / shares $ 8.76
Debt issuance cost, stock options issued, exercise price (in dollars per share) | $ / shares 0
Exercised, weighted average exercise price (in dollars per share) | $ / shares 2.91
Forfeited, weighted average exercise price (in dollars per share) | $ / shares 10.45
Expired, weighted average exercise price (in dollars per share) | $ / shares 10.04
Ending balance, weighted average exercise price (in dollars per share) | $ / shares 8.64
Options vested and expected to vest, weighted average exercise price (in dollars per share) | $ / shares 8.64
Options vested and exercisable, weighted average exercise price (in dollars per share) | $ / shares $ 5.42
Options remaining contractual term 7 years 7 months 6 days
Options vested and expected to vest, remaining contractual term 8 years 9 months 18 days
Options vested and exercisable, remaining contractual term 5 years
Options aggregate intrinsic value | $ $ 0
Options vested and expected to vest, aggregate intrinsic value | $ 0
Options vested and exercisable, aggregate intrinsic value | $ $ 0